International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

Authors

Luke Fletcher (ORCID: https://orcid.org/0000-0002-1146-763X)
Elise Mitri (ORCID: https://orcid.org/0000-0002-1250-2847)
Camille Paynter (ORCID: https://orcid.org/0000-0002-1845-126X)
Sara Vogrin (ORCID: https://orcid.org/0000-0002-1597-9421)
Marlena Klaic (ORCID: https://orcid.org/0000-0003-2328-0503)
Courtney Ierano (ORCID: https://orcid.org/0000-0002-5472-8895)
Jason A. Trubiano (ORCID: https://orcid.org/0000-0002-5111-6367)
Fiona James (ORCID: https://orcid.org/0000-0003-0469-5666)
Irvin Ng (ORCID: https://orcid.org/0000-0002-1357-4666)
Natasha E. Holmes (ORCID: https://orcid.org/0000-0001-8501-4054)
Suran L. Fernando (ORCID: https://orcid.org/0000-0003-0539-3176)

Institutions

The University of Sydney (AU)
The University of Queensland (AU)
The University of Melbourne (AU)
Royal Brisbane and Women's Hospital (AU)
Royal North Shore Hospital (AU)
Metro South Health (AU)
Peter Doherty Institute (AU)
Austin Health (AU)
Université de Nîmes (FR)

Publication Details

Journal: PLoS ONE
Published: 2025-09-05
DOI: https://doi.org/10.1371/journal.pone.0330724
Citations: 2
Primary Topic: Drug-Induced Adverse Reactions
Type: article
Field-Weighted Citation Impact: 2.79

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

Luke Fletcher, Elise Mitri, Camille Paynter, Sara Vogrin et al.

Sep 5, 2025

2 citations

PLoS ONE

Drug-Induced Adverse Reactions

2.79

article

International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

Luke Fletcher, Elise Mitri, Camille Paynter, Sara Vogrin, Marlena Klaic, Courtney Ierano, Jason A. Trubiano, Fiona James, Irvin Ng, Natasha E. Holmes, Suran L. Fernando

September 5, 2025article en

2 citations

Abstract

No abstract available for this paper.

PLoS ONEVol. 20(9)

The University of Sydney (AU), The University of Queensland (AU), The University of Melbourne (AU), Royal Brisbane and Women's Hospital (AU), Royal North Shore Hospital (AU), Metro South Health (AU), Peter Doherty Institute (AU), Austin Health (AU), Université de Nîmes (FR)

Openalex Percentile: Top 9%

Drug-Induced Adverse Reactions

2.79

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge — Luke Fletcher, Elise Mitri, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS